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The tightjunction, orzonula occludens, forms an intercellularbarrierbetween epithelial cells
within the gastrointestinal tract and liver and, by limiting the movement of water and solutes
through the intercellular space, maintains the physicochemical separation of tissue compart-
ments. The paracellular barrier properties ofjunctions are regulated and quite different among
epithelia. ThejunLtion also forms an intramembrane barrierbetween the apical and basolateral
membrane domains, contributing to segregation ofbiochemically distinct components ofthese
plasma membrane surfaces. Here we briefly review three rapidly developing areas ofmedically
relevant basic knowledge about the tight junction. First, we describe the presently incomplete
knowledge ofthe molecular structure ofthe tightjunction as a framework for understanding its
functional properties. Second, we consider experimental evidence defining how the barrier
properties of junctions are physiologically regulated and, third, how barrier properties are
specifically altered in, and contribute to, pathologic processes affecting epithelia.
INTRODUCTION
Epithelia are composed of sheets of polarized cells capable ofvectorial transport
ofwater and solutes. The space between individual epithelial cells must be sealed so
that transepithelial osmotic and electrical gradients are maintained. The structure
which creates this paracellular barrier is the tight junction. Characteristics of the
tight-junction barrier vary widely among different epithelia. The magnitude of the
barrier, measured by transjunctional electrical resistance, varies over several orders
ofmagnitude, creating so-called "leaky" epithelia such as that lining the gallbladder
and "tight" epithelia such as those found in the stomach and colon [1]. Another
variable property is the size ofparticles permitted to traverse the paracellular space
between cells, typically in the range of0.8 to 1.8 nm [2]. In combination with specific
transcellular transport mechanisms, theparacellular barrier properties of tight junc-
tions define the basic physiology of epithelia and, if altered, may significantly
contribute to epithelial pathology. In this review, we consider what is presently
known ofthe molecular structure ofthe tightjunction, which is an emerging area of
study and has already begun to contribute to our understanding of its functional
properties. We then consider both the normal physiologic regulation ofjunctions as
well as their alterations in pathologic states. We focus, for the most part, on
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FIG. 1. Schematic diagram of the intercellular junctions of epithelial cells (left) and model of the
molecular organization of the tight junction (right). Epithelial cells are joined by a recognizable set of
intercellular junctions (see text for details). The apical most of these is the tightjunction, which forms a
continuous zone of intercellular contact around cells. The tightjunction is formed by rows of contiguous
transmembrane proteins which traverse the intercellular space and contact similar proteins on adjacent
cells. Aplaque ofcytoplasmic proteins includingZO-1 (two isoforms), ZO-2, and cingulin are found along
the regions of intracellular contact. Actin microfilaments enter the plaque and presumably link the tight
junction with thecytoskeleton. ZO-1 and ZO-2 are known to associate physically; allother specificprotein
interactions are presently undefined. Barsignifies 20 microns.
physiology and pathology of the gastrointestinal tract; however, conclusions derived
from these observations can probably be generalized to epithelia ofother organs as
well as the vascular barriers formed bytightjunctionsbetween endothelial cells.
Several excellent reviews exist ofthe individual topics covered here [1,3-6].
MOLECULAR STRUCTURE OF THE TIGHT JUNCTION
Light microscopic study of the epithelia during the late nineteenth century
described a specialized region at the apical end ofintracellularborders referred to as
the "terminal bar" [7]. Itwas assumed that thisregion served an adhesive andbarrier
functionbetween the individual epithelial cells. With theintroduction ofthe electron
microscope, this region of cell-cell contact was further defined to be composed of
several different identifiable intercellular junctions (Fig. 1). Among these are
desmosomes, which serve an adhesive function; gapjunctions, which create intercel-
lular pores, allowing communication of small molecules between adjacent cells; and
adherensjunctions, which arepresently assumed to provide intercellular adhesion as
well as being a prominent site for attachment of the actomyosin cytoskeletal [8,9].
Invariably the apical most of these intracellular junctions is the tight junction, or
zonula occludens. Early electron microscopic studies demonstrated an absolute
11
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intercellular barrier to diffusion at the tight junction, using electron-dense tracer
molecules like colloidal lanthanum [10]. Coupled with static electron microscopic
images, this finding led to the misconception ofthe tightjunction as an absolute and
non-regulated barrier. In cross-sectional images, the tight-junction region is com-
posed of a variable number of points, or "kisses," at which the membranes of
adjacent cells come into very close contact. Ultrastructural studies have demon-
strated that actin microfilaments terminate on the membrane near these sites
[11,12], although the actin in this region is quantitatively much less concentrated
than at the adherens junction, where a dense circumferential ring of actin is
associated with the membrane.
Ultrastructural details of the tight junction are better defined using the freeze-
fracture electron microscopy technique. When frozen tissue is fractured, the cleav-
age plane tends to travel between the lipid bilayers of the plasma membrane. When
the fractured surface is shadowed with platinum and viewed in the electron micro-
scope, the zone of the tight junction appears as an anastomosing collection offibrils
within the membrane, circling the apical-basolateral boundary of the cell [13,14]. In
tissue which is not fixed with aldehydes, the fibrils appear to be composed ofrows of
intramembrane particles, which are assumed to be transmembrane proteins. Sites of
membrane contact correspond to these rows of transmembrane proteins, and it is
further assumed that the homotypic interaction of these proteins between adjacent
cells creates the intercellular resistive barrier. This assumption is further supported
by the positive correlation between the number of fibrils and the paracellular
electrical resistance observed among some epithelia [13,15].
Several components ofthe junction have recently been identified, all ofwhich are
peripherally associated membrane proteins present in a cytoplasmic plaque under
the sites ofcell-cell contact (Fig. 1). The first ofthese is ZO-1 (zonula occludens one),
which is an approximately 220 kDa phosphoprotein, located specifically under the
transmembrane particles [16-18]. Recent cDNA sequencing has demonstrated two
isoforms ofthe ZO-1 protein that differby an internal 80 amino acid domain referred
to as motif-a, which appears to result from alternative RNA splicing [19]. The cell-
and junction-specific distribution of ZO-1 isoforms (ZO-la+; ZO-1a-) is presently
undefined, but we speculate that differential expression may contribute to the great
diversity in junction properties observed among tissues. A second junction-specific
protein is cingulin [20], which is more abundant than ZO-1 and, through ultrastruc-
tural immunogold localization, appears to be located about three times as far from
the membrane bilayer [18]. Rotary-shadowed electron microscopic images of puri-
fied cingulin demonstrate the molecule to be a highly extended dimer [21], and
preliminary cDNA sequence information predicts it to contain alpha-helical struc-
ture homologous to that of tropomyosin and the tail of myosin II [22]. By analogy
with these known cytoskeletal proteins, this finding suggests that cingulin may serve
as a linker molecule between the subjunctional plaque and the cytoskeleton. A third
junction protein, termed ZO-2, has been identified in cultured epithelial cells
through its ability to bind and be immunoprecipitated with ZO-1 [23]. At the present
time, there are no specific probes, such as antibodies and cDNAs, for its study; thus,
its cellular and tissue distribution are undefined. Finally, a component referred to as
the BG9.1 antigen has been described and shows an immunolocalization very similar
to that of ZO-1 and cingulin; however, no subsequent reports of this protein have
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followed [24]. Features of the molecular structure and components of the tight
junction are presented schematically in Fig. 1.
PHYSIOLOGIC REGULATION OF THE TIGHT JUNCTION
The barrier properties of tight junctions vary among different epithelia and are
regulated by a variety of stimuli within epithelia in response to physiologic demands
[5]. The molecular mechanisms that bring this regulation about are not known, and
interpretation of many results in this area remains problematic because changes in
paracellular permeability have not been distinguished from changes in membrane
conductance. Nevertheless, enough examples exist to suggest at least two general
mechanisms for regulation of the permeability through the tight junction. First,
hormones and other agents act through second-messenger pathways to affect directly
junctional components, presumably through regulation of protein phosphorylation.
The ultimate targets of kinase/phosphatase cascades remain unresolved, although
both ZO-1 [17] and cingulin [25] are phosphoproteins. Second, alterations of the
actin cytoskeleton could result in secondary changes in intercellular junction con-
tacts. Some examples supporting each mechanism are cited below; these mechanisms
are not mutually exclusive but may act together to alter tight junction permeability.
Both circulating hormones and neuronal influences can change paracellular
resistance. In the perfused rat liver, vasopressin, epinephrine, and angiotensin II
rapidly increase the tight-junction permeability [26]. Cholinergic stimulation of
pancreas [27,28], parotid gland [29], and intestinal crypt cells causes penetration
through the tight junction of normally excluded ultrastructural tracers. In the same
studies, villus epithelial tight junctions were unaffected, suggesting a differential
crypt to villus regulation [30]. There are fewer examples of hormones which
"tighten" junctions, e.g., thyrotropin releasing hormone increases transepithelial
electrical resistance in monolayers of cultured MDCK cells [32].
The Role ofthe Protein Kinase C Pathway
Vasopressin, angiotensin II, and epinephrine all act through changes in calcium,
the inositol polyphosphates, and diacylglycerol. The effects of these hormones on
paracellular resistance in the isolated, perfused rat liver can be mimicked by the use
ofthe Ca++ ionophore, A23187 [33], and an inhibitor of microsomal Ca++ sequestra-
tion, 2,5-di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ [34]). Recently, two sepa-
rate intracellular pathways have been proposed to explain the increase in tight
junction permeability that follows the vasopressin-induced intracellular calcium
increase in isolated hepatocytes. Yamaguchi et al. [35] demonstrated that vasopres-
sin stimulates myosin light-chain phosphorylation, which is hypothesized to produce
microfilament contraction. Nathanson et al. [36] have presented evidence that
calcium acts by activation of protein kinase C (PKC), presumably by altering
phosphorylation of proteins other than the myosin light chain or its kinase. Similar
results have been demonstrated in the human intestinal T84 cell line, where an
increase in paracellular permeability produced by a Ca++ ionophore can be blocked
by two PKC inhibitors but not by a calmodulin inhibitor [37]. These observations are
consistent with the involvement of the protein kinase C pathway in regulation of
paracellular permeability.
Changes in Ca++ levels are not only important in the hormonal regulation of the
tightjunction but have been implicated in regulation of its assembly and disassembly.
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Tight junctions are very sensitive to Ca++; removal of this ion from the medium
opens the junctional complex between most cells, including intestinal cells [38],
oxyntic cells of gastric glands [39], pancreatic acinar cells [40], and monolayers of
MDCK cells [41]. Switching cultured epithelial cells from growth in low (<5 JIM)
Ca++ to normal Ca++ levels inducesjunction assembly and formation oftransepithe-
lial electrical resistance, the so-called "Ca++-switch" protocol [42,43]. Studying the
process of tight-junction assembly and sealing in MDCK cells, Balda et al. [44]
demonstrated that the activation of the phospholipase C/protein kinase C pathway
enhances the development of transepithelial resistance. In contrast, inhibition of
calmodulin blocks the development of transepithelial resistance. Placing cultured
monolayers in Ca++-free medium causes loss ofZO-1 from the membrane; switching
these cells back into Ca++-containing medium causes reassembly of ZO-1 on to the
tight junction [31]. Preliminary experiments indicate that, even in the absence of
calcium, the activation of protein kinase C induces the association of the ZO-1
protein with thejunctional area [32]. Furthermore, ifcells are treated with a protein
kinase Cinhibitor, ZO-1 does not associate with the membrane atthejunctional area
duringthe Ca++ switch [45]. Protein kinase Caction is notsimplyinvolved injunction
assembly, however, since the disassembly of tight junction induced by removal of
extracellular Ca++ isblockedbyPKCinhibitors [46]. These observations suggest that
the PKC pathway may have direct effects on the protein components of the tight
junction, altering their assembly and disassembly, but whether the Ca++-switch
model is applicable to physiologic regulation is unclear.
TheRole oftheProtein KinaseA Pathway
The role of the adenylyl cyclase-protein kinase A pathway has also been studied
and implicated in junctional regulation. In some epithelia, the transepithelial
resistance increases in response to increases in cAMP [47-49], in others it decreases
[50-52], and, in one study, the increase in permeability oftightjunctions induced by
cAMP was selective for Cl- [53]. There is evidence that the actions ofprotein kinase
A and C are antagonistic. For example, in the Ca++-switch model of junction
assembly described above, protein kinase A activation inhibits junction assembly,
while protein kinase C activation augments it. The lack of a consistent response and
the failure of some studies to differentiate between changes in paracellular perme-
ability from effects on membrane conductance make it difficult to define the site or
mechanism ofprotein kinase A-mediated regulation.
TheRole oftheMembrane-Associated Cytoskeleton
Evidence for the cytoskeletal regulation hypothesis comes from diverse but
complementary observations. The anatomic approximation of microfilaments to the
tight-junctional region of epithelial cells suggests a functional relationship. Indeed,
several investigators have observed that drugs active against microfilaments change
tight-junctional permeability and/or structure in a variety of epithelia [42,54-56].
The observation that vasopressin stimulates myosin light-chain phosphorylation
coincident with increased junctional permeability in the liver supports this idea.
Several slow-acting hormones have been demonstrated to have coincident effects on
actin organization and paracellular resistance. For example, the addition of insulin
to established monolayers ofhuman colonicepithelial cells (T84) causesthe transep-
ithelial resistance to decline more than eightfold over a three- to four-day period.
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Together with this increased permeability, a subtle condensation of the perijunc-
tional actin ringhasbeen observed [57]. Interferon gamma appears to affect cultured
intestinal epithelial cells in a similar fashion [58].
Recent studies performed in rodent intestine have demonstrated that glucose and
amino acids can induce a significant increase in paracellular permeability coincident
with condensation ofthe perijunctional microfilaments [59]. This discoveryhas led to
the fascinating hypothesis that nutrient solutes triggercontraction ofthe membrane-
associated cytoskeletal ring, increase junctional permeability, and enhance absorp-
tion through solvent drag [59-61]. Presumably the intermediary signal could be one
ofthe second messenger cascades discussed above.
In summary, the regulation oftight-junction permeability seems to be a multi-step
process which involves several signal transduction pathways, activated through
different stimuli in different cell types. The loci for regulation are poorly defined but
mayinvolve both specific regulation ofjunction proteins oralterations in cytoskeletal
organization.
PATHOLOGIC ALTERATIONS OF THE TIGHT JUNCTION
Alterations in tight junctions occur in a number of experimental and clinical
conditions affecting the gastrointestinal system. These alterations, in general, have
beenobserved either at the structural level, manifestedbychanges in the appearance
ofthejunction, or at the functional level, manifested bychanges in indirect measures
ofparacellular permeability. Manyofthe pathologicconditions such as common bile
duct (CBD) obstruction ofthe liver [62,63] and manyofthe agents toxic tojunctions,
such as aspirin [64] and ethanol [65] in gastric mucosa, have complex effects on the
tissues studied, and the mechanism of injury to the tight junction and the contribu-
tion of junction dysfunction to the observed pathology are difficult to determine.
Nonetheless, analysis of some of these pathologic conditions and agents provides
insight intojunctional pathophysiology.
Phalloidin, an agent that stabilizes filamentous actin, when administered experi-
mentally, decreases bile flow [46,66] and results in a marked accumulation of
microfilaments aroundcanaliculiinhepatocytes [67]. Theseovertcytoskeletalchanges
are accompanied by disorganization and decreased numbers of hepatocyte tight
junction fibrils visualized by freeze-fracture electron microscopy and by increased
junctional permeability to electron-dense tracers [66]. This increased junctional
permeability is thought to contribute to cholestasis by dissipating electrochemical
gradients across the canaliculus and allowing the reflux of bile from the canaliculus
through thejunction into the sinusoid. These observations imply that an intact apical
cytoskeleton is required to maintain normal hepatocyte tightjunction structure and
function. The effects oftwo other microfilament toxins, cytochalasin D, which causes
peri-junctional actomyosin ring contraction and increased tightjunction permeabil-
ity in the intestine [56], and cytochalasin B, which disperses microfilaments in
hepatocytes and also impairs bile flow [68], support the notion that disruption ofthe
cytoskeleton in turn disrupts the tightjunction.
Interestingly, two inherited pediatric cholestatic liver disorders-Byler's disease
[69] and North American Indian childhood cirrhosis [70]-have histologic features
which are quite similar to experimental phalloidin injury and may be examples of
inborn defects in cytoskeletal organization which result in tight-junction dysfunction.
Another form ofcholestasis, that associated with CBD obstruction, also results in
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FIG. 2. Indirect immuno-
fluorescence localization of
ZO-1 in hepatocyte tight
junctions of rat liver, before
(control) and 72 hours (ligat-
ed) after ligation ofthe com-
mon bile duct. In normal
liver,ZO-1 ispositionedcon-
tinuously along tight junc-
tionswhich borderboth sides
ofthe canalicular membrane
surfaces. Following common
bile duct ligation, the local-
ization of ZO-1 becomes
irregular and in places dis-
?i
`. continuous. Thischange sug-
gests loss of integrity of the
structure which seals the
paracellular space as a con-
tributing factor in cholestasis.
structural and functional disruption of the tight junction. Electron microscope
studies in experimental models [62], and in human tissue [63] have shown ultrastruc-
tural alterations similar to those seen with cytoskeletal disruption induced by
phalloidin and have demonstrated increased paracellular permeability to electron-
dense tracers. More recently, the immunolocalization of a tight junction-specific
protein, ZO-1, has been shown to be disturbed after experimental CBD obstruction
[71], supporting the theorythatthe molecular structureofthejunction isdisrupted in
this form of injury (Fig. 2). Taken together, these findings support a role for tight
junction disruption in the pathogenesis of obstructive cholestasis and suggest that
primaryinjurytothecytoskeleton mayunderlie the disruptionofthe tightjunction. It
is tempting to speculate that similar cytoskeletal and tight junction damage may be
important in the pathogenesis ofinjury related toobstruction ofotherluminal organs
such as the bowel, the pancreas, and the kidney.
Intestinal epithelial tight junction abnormalities have also been observed in
experimental and clinical pathologic conditions. Studies in a human intestinal
epithelial cell line (T84) have shown that Clostridium difficle toxin A markedly
decreases transepithelial resistance by increasing tight junction permeability. This
permeability defect occurs in the absence of inflammatory cells, is associated with
cytoskeletal disruption as measured bystainingofthe actin-binding drug rhodamine-
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phalloidin, and is postulated to contribute to diarrhea by dissipating transepithelial
electrochemical gradients needed forproperintestinal absorption and secretion [72].
Another junctional toxin designated ZOT has been found in attenuated Vibio
cholerae vaccine strains which do not produce cholera toxin but retain the ability to
cause mild diarrhea. This toxin decreases ileal transepithelial resistance and alters
the freeze-fracture electron microscopic appearance of the junction in a manner
similar to phalloidin and extrahepatic biliary obstruction [73]. These observations
again suggest that cytoskeletal damage may be a primary event in many forms of
junction injury and suggest that toxin injury of the cytoskeleton and tight junction
may be an under-appreciated mechanism of diarrhea production by infectious
agents.
A variety of drugs and clinical agents have also been shown to disrupt intestinal
epithelial tight junctions. For example, the effects of aspirin on junction structure
when applied for short periods oftime to canine gastric mucosa have been assessed
[64]. Here, epithelial tightjunction ultrastructure is distorted andjunctional perme-
ability to electron-dense tracers increased after exposures of less than one hour.
Ethanol [65] and other agents (reviewed in [1]) also disrupt gastric mucosaljunction
ultrastructure and have led to the concept that many agents may initiate and amplify
gastric mucosal injury by increasing tight junction permeability and allowing back-
diffusion ofH+ ions into the mucosa.
The idea that increased intestinal tight junction permeability may increase the
predisposition to mucosal damagebyweakening the intestinal barrier is not confined
to noxious agents in the stomach. There is ultrastructural [74] and functional
evidence [75] that patients with Crohn's disease and their relatives have abnormally
increased tight junction permeability. These observations suggest that in some
patients with inflammatory bowel disease a primary defect which allows entrance of
inflammatory agents into the mucosa is abnormal tightjunction permeability [76].
Although our understanding oftight-junction pathophysiology is rudimentary, it is
evident that epithelial tight-junction abnormalities occur after a wide variety of
insults to the gastrointestinal system. A recurring theme is emerging that disruption
of the cytoskeleton results in disruption of the tightjunction. This pathophysiologic
link is less surprisingwhen the close structural relationship between the cytoskeleton
and the tightjunction is considered. As we understand more about the tightjunction
and the cytoskeleton and they are viewed less as static barrier and scaffolding and
more as dynamic, closely interacting cellular components, then it may be less
surprising that some pathologic junction states will be an extension of normal
physiologic regulation ofthe tightjunction.
CONCLUSION
The last 30 years have seen accelerated recognition that the properties of the
paracellular path between epithelial cells is quite variable and physiologically
regulated. Progress inunderstandingthe molecularbasisofthese properties hasonly
very recently come through identification and characterization of several protein
components of the tightjunction. Here we have suggested that the tightjunction be
considered a component of the apical cytoskeleton and that much physiologic
regulation and pathologic alteration can be considered in terms of alteration in
cytoskeletal, and actin, organization. Second-messenger signaling pathways (e.g.,
PKC, Ca++) may affect the cytoskeleton or act directly on junction components
through protein phosphokinases and phosphatases. Detailed insight into how the
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paracellular barrier ofepithelia is regulated and altered in disease will require more
information about its molecular structure. The goal of this information is to define
ways to correct pathologically defective barrier properties, prevent these defects, or
to alter them fortherapeutic purposes such as drug delivery.
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